Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
Grupo Español de Investigación en Cáncer de Ovario
Case Comprehensive Cancer Center
University of California, Davis
The First Affiliated Hospital of Soochow University
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
ARCAGY/ GINECO GROUP
Leiden University Medical Center
Fundacion Clinic per a la Recerca Biomédica
Memorial Sloan Kettering Cancer Center
Baylor Research Institute
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Institut Claudius Regaud
Oncology Institute of Southern Switzerland
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
University of Pennsylvania
Imperial College Healthcare NHS Trust
University of Chicago
Dana-Farber Cancer Institute
Instituto do Cancer do Estado de São Paulo
Memorial Sloan Kettering Cancer Center
University of Washington
University Health Network, Toronto
Stanford University
Università degli Studi dell'Insubria
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Northwestern University
Institut du Cancer de Montpellier - Val d'Aurelle
Ente Ospedaliero Ospedali Galliera
European Institute of Oncology
University of Pittsburgh
Mercy Medical Center
Haukeland University Hospital
Hospices Civils de Lyon
Cukurova University
University of Pittsburgh
Shantou University Medical College
Seoul National University Hospital
Tongji Hospital
University Hospital, Geneva
Yale University
University of Leeds
University Medical Center Groningen
University Medical Center Groningen
Chongqing University Cancer Hospital
Second Affiliated Hospital of Wenzhou Medical University
The First Hospital of Jilin University